JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1999; 34:830-836
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henrion, D.
Right arrow Articles by Lévy, B. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henrion, D.
Right arrow Articles by Lévy, B. I.

CLINICAL STUDIES

The deletion genotype of the angiotensin I-converting enzyme is associated with an increased vascular reactivity in vivo and in vitro

Daniel Henrion, PhDa, Joelle Benessiano, PhD*, Ivan Philip, MD#, Sandrine Vuillaumier-Barrot, PhD*, Marc Iglarz, BSc*, Gaetan Plantefève, MD#, Didier Chatel, MD§, Ulrich Hvass, MD§, Geneviève Durand, PhD*, Jean-Marie Desmonts, MD#, Philippe Amouyel, MD** and Bernard I. Lévy, MD, PhDa

a Institut National de la Santé et de la Recherche Médicale (INSERM) U 141, IFR Circulation, Université Paris VII, Hôpital Lariboisière, Paris, France
* Laboratoire de Biochimie, Hôpital Xavier Bichat, Paris, France
# Service d’Anesthésie-Réanimation, Hôpital Xavier Bichat, Paris, France
§ Service de Chirurgie Cardiaque, Hôpital Xavier Bichat, Paris, France
** Service d’Epidémiologie et de Santé Publique, Institut Pasteur, Lille, France

Manuscript received May 28, 1998; revised manuscript received April 16, 1999, accepted June 3, 1999.

Reprint requests and correspondence: D. Henrion, PHD, INSERM U 141, 41 Bd de la Chapelle, 75475 Paris, Cedex 10, France
daniel.henrion{at}inserm.lrb.ap-hop-paris.fr

OBJECTIVES

To define a link between the deletion genotype (DD) and vascular reactivity, we studied in vivo and in vitro phenylephrine (PE)-induced tone and the effect of angiotensin II (AII) at physiological (subthreshold) concentrations on PE-induced tone.

BACKGROUND

The deletion allele (D) of the angiotensin I-converting enzyme (ACE) has been associated with a higher circulating and cellular ACE activity and possibly with some cardiovascular diseases.

METHODS

During cardiac surgery PE-induced contraction was studied in patients with excessive hypotension. In parallel, excess material of internal mammary artery, isolated from patients operated for bypass surgery, was mounted in an organ chamber, in vitro, for isometric vascular wall force measurement.

RESULTS

In patients under extracorporeal circulation, PE (25 to 150 µg) induced higher contractions in patients with the DD genotype (e.g., with PE 75 µg: 20.3 ± 2.9 vs. 11.5 ± 2.5 mm Hg/ml per min, DD vs. II/ID, n = 15 vs. 30, p < 0.03). In the mammary artery, in vitro, contractions to PE (0.1 to 100 µmol/liter) or AII (1 or 100 nmol/liter) were not affected by the genotype. Angiotensin II (10 pmol/liter) significantly potentiated PE (1 µmol/liter)-induced contraction in both groups. Potentiation of PE-induced tone by AII was significantly higher in the DD than in the II/ID group.

CONCLUSIONS

The DD genotype was associated with an increased reactivity to PE in vivo and potentiating effect of exogenous AII in vitro. The higher response to PE in vivo might reflect a higher potentiation by endogenous AII. These data should be considered to understand possible link(s) between cardiovascular disorders and the ACE gene polymorphism.

Abbreviations and Acronyms
  ACE = angiotensin I-converting enzyme
  AII = angiotensin II
  CPB = cardiopulmonary bypass
  DD = deletion genotype
  DRC = dose-response curve
  I = insertion
  MAP = mean arterial pressure
  PE = phenylephrine




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
M. V. Podgoreanu and D. A. Schwinn
New Paradigms in Cardiovascular Medicine: Emerging Technologies and Practices: Perioperative Genomics
J. Am. Coll. Cardiol., December 6, 2005; 46(11): 1965 - 1977.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
L. Bahi, N. Koulmann, H. Sanchez, I. Momken, V. Veksler, A. X. Bigard, and R. Ventura-Clapier
Does ACE inhibition enhance endurance performance and muscle energy metabolism in rats?
J Appl Physiol, January 1, 2004; 96(1): 59 - 64.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Iglarz, J. Benessiano, I. Philip, S. Vuillaumier-Barrot, S. Lasocki, U. Hvass, G. Durand, J.-M. Desmonts, B. I. Levy, and D. Henrion
Preproendothelin-1 Gene Polymorphism Is Related to a Change in Vascular Reactivity in the Human Mammary Artery In Vitro
Hypertension, February 1, 2002; 39(2): 209 - 213.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K. Schwartz
Polymorphism in coronary artery vasoconstriction
Eur. Heart J., May 2, 2001; 22(10): 804 - 806.
[PDF]


Home page
J Am Coll CardiolHome page
A. Prasad, S. Narayanan, M. A. Waclawiw, N. Epstein, and A. A. Quyyumi
The insertion/deletion polymorphism of the angiotensin-converting enzyme gene determines coronary vascular tone and nitric oxide activity
J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1579 - 1586.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1999 by the American College of Cardiology Foundation.